Sustained visual acuity loss in the comparison of age-related macular degeneration treatments trials

Although anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration (AMD) results in improved vision overall, loss of substantial vision can occur. Understanding the processes that lead to loss of vision may lead to preventive strategies. To determine the incid...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	JAMA ophthalmology Jg. 132; H. 8; S. 915
Hauptverfasser:	Ying, Gui-shuang, Kim, Benjamin J, Maguire, Maureen G, Huang, Jiayan, Daniel, Ebenezer, Jaffe, Glenn J, Grunwald, Juan E, Blinder, Kevin J, Flaxel, Christina J, Rahhal, Firas, Regillo, Carl, Martin, Daniel F
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.08.2014
Schlagworte:	Aged Antibodies, Monoclonal, Humanized - therapeutic use Bevacizumab Humans Incidence Macular Degeneration - drug therapy Macular Degeneration - physiopathology Middle Aged Ranibizumab Visual Acuity
ISSN:	2168-6173, 2168-6173
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!